Evidence map›Paper›PMID 30828727›Full record

ArticleNeuro-oncology2019

A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.

Roshan S Prabhu, Brandon E Turner, Anthony L Asher, Samuel R Marcrom, John B Fiveash, Paul M Foreman, Robert H Press, Kirtesh R Patel, Walter J Curran, William G Breen and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 4 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 4 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Roshan S PrabhuLevine Cancer Institute, Atrium Health, Charlotte, North Carolina.
Brandon E TurnerDepartment of Radiation Oncology, Stanford University, Stanford, California.
Anthony L AsherLevine Cancer Institute, Atrium Health, Charlotte, North Carolina.
Samuel R MarcromUniversity of Alabama at Birmingham, Birmingham, Alabama.
John B FiveashUniversity of Alabama at Birmingham, Birmingham, Alabama.
Paul M ForemanUniversity of Alabama at Birmingham, Birmingham, Alabama.
Robert H PressWinship Cancer Institute of Emory University, Atlanta, Georgia.
Kirtesh R PatelYale University School of Medicine, New Haven, Connecticut.
Walter J CurranWinship Cancer Institute of Emory University, Atlanta, Georgia.
William G BreenMayo Clinic, Rochester, Minnesota.
Paul D BrownMayo Clinic, Rochester, Minnesota.
Krishan R JethwaMayo Clinic, Rochester, Minnesota.
Inga S GrillsBeaumont Health, Royal Oak, Michigan.
Jessica D ArdenBeaumont Health, Royal Oak, Michigan.
Lauren M FosterOakland University William Beaumont School of Medicine, Auburn Hills, Michigan.
Matthew A ManningCone Health Cancer Center, Greensboro, North Carolina.
Joseph D SternCarolina Neurosurgery and Spine Associates, Charlotte, North Carolina.
Scott G SoltysDepartment of Radiation Oncology, Stanford University, Stanford, California.
Stuart H BurriLevine Cancer Institute, Atrium Health, Charlotte, North Carolina.
Mayo Clinic · USUniversity of Alabama at Birmingham · USBeaumont Health · USCone Health · USEmory University · USStanford University · USCarolina Neurosurgery and Spine Associates · USLevine Cancer Institute · USOakland University · USSoutheast Radiation Oncology Group · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiographic leptomeningeal disease (LMD) develops in up to 30% of patients following postoperative stereotactic radiosurgery (SRS) for brain metastases. However, the clinical relevancy of this finding and outcomes after various salvage treatments are not known.

methodsPatients with brain metastases, of which 1 was resected and treated with adjunctive SRS, and who subsequently developed LMD were combined from 7 tertiary care centers. LMD pattern was categorized as nodular (nLMD) or classical ("sugarcoating," cLMD).

resultsThe study cohort was 147 patients. Most patients (60%) were symptomatic at LMD presentation, with cLMD more likely to be symptomatic than nLMD (71% vs. 51%, P = 0.01). Salvage therapy was whole brain radiotherapy (WBRT) alone (47%), SRS (27%), craniospinal radiotherapy (RT) (10%), and other (16%), with 58% receiving a WBRT-containing regimen. WBRT was associated with lower second LMD recurrence compared with focal RT (40% vs 68%, P = 0.02). Patients with nLMD had longer median overall survival (OS) than those with cLMD (8.2 vs 3.3 mo, P < 0.001). On multivariable analysis for OS, pattern of initial LMD (nodular vs classical) was significant, but type of salvage RT (WBRT vs focal) was not.

conclusionsNodular LMD is a distinct pattern of LMD associated with postoperative SRS that is less likely to be symptomatic and has better OS outcomes than classical "sugarcoating" LMD. Although focal RT demonstrated increased second LMD recurrence compared with WBRT, there was no associated OS detriment. Focal cranial RT for nLMD recurrence after surgery and SRS for brain metastases may be a reasonable alternative to WBRT.

Indexed as

Brain NeoplasmsMeningeal NeoplasmsRadiosurgeryCranial IrradiationHumansRetrospective StudiesSalvage Therapybrain metastasesleptomeningeal diseasepostoperative radiosurgeryradiosurgery

Identifiers

PMID30828727
PMCPMC6682204
OpenAlexW2918189147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.